Top compounds associated with response to TNPO2


Feature Type Standardized
Nominal ANOVA
mRNA pifithrin-mu CTRPv2 pan-cancer AAC 0.19 2e-07
mRNA UNC0638:navitoclax (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.2 2e-07
mRNA Compound 7d-cis CTRPv2 pan-cancer AAC 0.2 3e-07
mRNA decitabine:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.17 3e-07
mRNA vincristine CTRPv2 pan-cancer AAC 0.16 4e-07
mRNA 17-AAG GDSC1000 pan-cancer AAC -0.16 4e-07
mRNA navitoclax:sorafenib (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.19 5e-07
mRNA navitoclax:piperlongumine (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.18 1e-06
mRNA RG-108 CTRPv2 pan-cancer AAC 0.18 2e-06
mRNA GSK1070916 GDSC1000 pan-cancer AAC 0.15 2e-06
Download CSV